CD4 and neoplasm: Liu et al. analyzed the tumour immune landscape 528 patients with colon cancer (224 KRASmt and 304 KRASwt) and observed downregulation of immunoactive cells such as native B cells, M1 macrophages and CD4 memory T cells and abundance of immunosuppressive Tregs in KRASmt tumours [70].